[
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "primary_growth"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "primary_growth"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "primary_growth"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "primary_growth"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "primary_growth"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "primary_growth"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "primary_growth"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "primary_growth"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "primary_growth"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "primary_growth"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "primary_growth"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "primary_growth"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "primary_growth"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "primary_growth"
  },
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "local_invasion"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "local_invasion"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "local_invasion"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "local_invasion"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "local_invasion"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "local_invasion"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "local_invasion"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "local_invasion"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "local_invasion"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "local_invasion"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "local_invasion"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "local_invasion"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "local_invasion"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "local_invasion"
  },
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "intravasation"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "intravasation"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "intravasation"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "intravasation"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "intravasation"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "intravasation"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "intravasation"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "intravasation"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "intravasation"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "intravasation"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "intravasation"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "intravasation"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "intravasation"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "intravasation"
  },
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "survival_in_circulation"
  },
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "extravasation"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "extravasation"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "extravasation"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "extravasation"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "extravasation"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "extravasation"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "extravasation"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "extravasation"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "extravasation"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "extravasation"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "extravasation"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "extravasation"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "extravasation"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "extravasation"
  },
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "micrometastasis_formation"
  },
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "angiogenesis"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "angiogenesis"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "angiogenesis"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "angiogenesis"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "angiogenesis"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "angiogenesis"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "angiogenesis"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "angiogenesis"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "angiogenesis"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "angiogenesis"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "angiogenesis"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "angiogenesis"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "angiogenesis"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "angiogenesis"
  },
  {
    "gene": "BCL2",
    "variant": "p.Gly101Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Anti-apoptotic, venetoclax target",
    "functionality": 0.5502210140228272,
    "essentiality": 0.35,
    "chromatin": 0.0375,
    "regulatory": 0.1,
    "target_lock_score": 0.3357023549079895,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "BRAF",
    "variant": "p.Val600Glu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved drugs (vemurafenib, dabrafenib)",
    "functionality": 0.6017843246459962,
    "essentiality": 0.352,
    "chromatin": 0.7516,
    "regulatory": 0.101,
    "target_lock_score": 0.46171451362609867,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "CXCR4",
    "variant": "p.Ser338Gly",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Chemokine receptor, homing signal",
    "functionality": 0.5502422332763672,
    "essentiality": 0.35,
    "chromatin": 0.8847,
    "regulatory": 0.1,
    "target_lock_score": 0.46278978164672846,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "HIF1A",
    "variant": "p.Pro582Leu",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Hypoxia master regulator",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7947,
    "regulatory": 0.1,
    "target_lock_score": 0.449205,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "ICAM1",
    "variant": "p.Arg241Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Cell adhesion molecule",
    "functionality": 0.5505272030830384,
    "essentiality": 0.351,
    "chromatin": 0.4425,
    "regulatory": 0.1,
    "target_lock_score": 0.39690952107906347,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "KRAS",
    "variant": "p.Gly12Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Common in pancreatic/colorectal cancer",
    "functionality": 0.5536637783050538,
    "essentiality": 0.354,
    "chromatin": 0.3243,
    "regulatory": 0.103,
    "target_lock_score": 0.38177732240676876,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "MET",
    "variant": "p.Asp1010Asn",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved MET inhibitors",
    "functionality": 0.5502406835556031,
    "essentiality": 0.35,
    "chromatin": 0.9021,
    "regulatory": 0.1,
    "target_lock_score": 0.465399239244461,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "MMP2",
    "variant": "p.Pro268Leu",
    "clinvar_classification": "Likely Pathogenic",
    "evidence_tier": "Tier 2 - Matrix metalloproteinase",
    "functionality": 0.5504023313522339,
    "essentiality": 0.35,
    "chromatin": 0.3111,
    "regulatory": 0.1,
    "target_lock_score": 0.3768058159732819,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "MMP9",
    "variant": "p.Arg279Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Invasion/metastasis",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.84,
    "regulatory": 0.1,
    "target_lock_score": 0.456,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "NRAS",
    "variant": "p.Gln61Arg",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - Melanoma driver",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.7091,
    "regulatory": 0.1,
    "target_lock_score": 0.436365,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "SNAI1",
    "variant": "p.Arg107Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT master regulator",
    "functionality": 0.5501476287841798,
    "essentiality": 0.35,
    "chromatin": 0.1068,
    "regulatory": 0.1,
    "target_lock_score": 0.3460716700744629,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "TGFB1",
    "variant": "p.Arg25Cys",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - Colonization promoter",
    "functionality": 0.55,
    "essentiality": 0.35,
    "chromatin": 0.9584,
    "regulatory": 0.1,
    "target_lock_score": 0.47376,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "TWIST1",
    "variant": "p.Arg154Gln",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 2 - EMT regulator, metastasis promoter",
    "functionality": 0.5501111030578614,
    "essentiality": 0.35,
    "chromatin": 0.1966,
    "regulatory": 0.1,
    "target_lock_score": 0.35952888607025146,
    "mission": "metastatic_colonization"
  },
  {
    "gene": "VEGFA",
    "variant": "p.Gly88Asp",
    "clinvar_classification": "Pathogenic",
    "evidence_tier": "Tier 1 - FDA approved anti-VEGF drugs",
    "functionality": 0.5501877546310425,
    "essentiality": 0.35,
    "chromatin": 0.7786,
    "regulatory": 0.1,
    "target_lock_score": 0.4468557141208649,
    "mission": "metastatic_colonization"
  }
]